ProtoPulse · CNAS therapeutic protocols
Data updated 19 Oct 2026, 22:37 · printed from ProtoPulse

LEUPRORELINUM

Active substance (INN) · ATC L02AE02 · 4 products authorised in Romania

◀ Back

Protocols it appears in

As a medicine of the protocol (in the title) or only mentioned in the text

Code	Protocol	Status	Role	Sublist	GP
L039C	LEUPRORELINUM	In force	medicine of the protocol	B si C2-P3	NO*
L040C	GOSERELINUM	In force	mentioned in the text	B si C2-P3	NO*

Authorised brand products (ANMDM)

The Romanian register of medicines for human use, updated daily

Brand name	Form	Strength	Holder	ATC	Rx
CAMCEVI 42 mg	SUSP. INJ. CU ELIB. PREL.	42mg	ACCORD HEALTHCARE S.L.U. - SPANIA	L02AE02	PR
ELIGARD 22,5 mg	PULB.+SOLV. PT. SOL. INJ.	22,5mg	RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.P.A - ITALIA	L02AE02	PR
ELIGARD 45 mg	PULB.+SOLV. PT. SOL. INJ.	45mg	RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.P.A. - ITALIA	L02AE02	PR
LEPTOPROL 5 mg	IMPLANT	5mg	SANDOZ PHARMACEUTICALS S.R.L. - ROMANIA	L02AE02	PR

Data extracted automatically from the documents published by CNAS (cnas.ro/protocoale-terapeutice) and from the ANMDM medicines register. For information only; the official text (the Ministry of Health / CNAS orders published in the Official Gazette) prevails. Protocol names and texts are shown in Romanian, as published.